Physicians debate stroke prevention strategies

10/15/2012 | New York Times (tiered subscription model), The

Although an invasive stroke prevention strategy is considered advisable for symptomatic patients who can withstand treatment, there is less accord on how to handle asymptomatic patients, according to this blog post. Experts do agree, however, that research comparing surgery, stenting and medical therapy is essential to clear up the issue.

View Full Article in:

New York Times (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park